Noxopharm Announces Pilot Study With Bristol Myers Squibb’s Product
Australian clinical-stage drug development company Noxopharm (ASX: NOX) is pleased to announce it has joined with Bristol Myers Squibb (NYSE: BMY) in […]
Bristol Myers Squibb Raises the Bar for Commitment to Minority and Underserved Populations
American pharmaceutical company Bristol Myers Squibb and its Bristol Myers Squibb Foundation have announced a $300 million investment as part […]
